ArticleScientific reports2026
Enhanced gait following NW-RSA training links to reduced myostatin and improved L-arginine metabolites in older women with preserved vitamin D.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Thirty women (age = 68.9 ± 6.04 years), with preserved vitamin D status and sedentary lifestyle, participated in the study, the aim of which was to evaluate the effects of Nordic walking training with additional loading (NW-RSA), on gait quality, muscle mass, and physical fitness in relation to changes in selected exerkines and nitric oxide metabolites. The training was conducted three times a week, for 12 weeks. All indicators were assessed before and after the intervention. Blood samples were collected at baseline, post-12 weeks, and 1 hour after the first and the last NW-RSA training session. NW-RSA induced significant enhancements in gait control, manifesting as increased walking cadence (3%), speed (6%), and step length (3%), and reduced step time (6%) (p<0.05). The improvement in muscle strength (isokinetic knee extension strength: peak torque (10%), total work (11%), and average power (18%) (p<0.01), and physical fitness (p<0.01) was registered. Those changes were accompanied by significantly decreased myostatin (18%, p<0.05) and carboxylated osteocalcin (15%, p<0.01) levels. The L-arginine concentration and L-arginine/ADMA ratio were increased (respectively 8% and 7%, p<0.05) post-training period. The first session of NW-RSA increased L-arginine concentration (18%, p<0.01) and decreased methylarginine (37%, p<0.01), and the last reduced the pro-inflammatory IL-18 (18%, p<0.01) and carboxylated osteocalcin (4%, p<0.05). NW-RSA training improved gait quality, muscle strength, and physical fitness in elderly women. These enhancements were associated with modifications in myostatin levels, the L-arginine/ADMA ratio, and carboxylated osteocalcin concentrations, all of which support muscle adaptive changes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.